Bevacizumab-100mg/4ml(Avastin)
Bevacizumab 100mg Injection is an advanced anti-cancer therapy that targets tumor blood supply by inhibiting VEGF. Doctors use it to treat multiple cancers, including colorectal, lung, and kidney cancers. This intravenous medication offers precise, targeted action, improving treatment outcomes and slowing disease progression. Administered under expert supervision, it ensures safety and effectiveness. Its reliable formulation supports consistent performance, making it a preferred choice in oncology care. Patients benefit from improved disease management when following prescribed treatment plans. Always consult a healthcare professional for proper usage and monitoring.
Description
Bevacizumab 100mg Injection is a targeted cancer therapy designed to inhibit the growth of blood vessels that supply tumors, helping to slow down or stop cancer progression. This monoclonal antibody works by blocking vascular endothelial growth factor (VEGF), effectively reducing the blood supply required for tumor growth. It is widely used in the treatment of various cancers, including colorectal cancer, lung cancer, kidney cancer, and certain types of brain tumors.
Healthcare professionals administer this injection intravenously under strict medical supervision, ensuring precise dosage and optimal therapeutic outcomes. Patients benefit from its targeted mechanism, which focuses specifically on cancer cells while minimizing damage to healthy tissues. This advanced therapy improves treatment effectiveness when used alone or in combination with chemotherapy.
The formulation ensures high purity and consistent performance, making it a trusted choice in oncology care. Regular monitoring during treatment helps manage potential side effects and enhances patient safety. Doctors recommend this therapy based on individual health conditions and cancer type, ensuring a personalized treatment approach.
Patients undergoing treatment often experience improved disease control and better quality of life when following prescribed medical guidance. It is essential to adhere strictly to the treatment schedule and consult a healthcare provider for any concerns during therapy.
- Drug Type: Monoclonal Antibody
- Active Ingredient: Bevacizumab
- Strength: 100mg/4ml
- Administration: Intravenous Injection
- Therapeutic Class: Anti-VEGF Cancer Therapy
- Usage: Treatment of various cancers
- Prescription Required: Yes
- Storage: Store as per medical guidelines
